Pey-Chang Kent Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pey-Chang Kent Lin has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
Sunil P. Khatri
Texas A&M University
6 shared publications- Sunil P. Khatri
Texas A&M University
1 shared publication
Latest Publications
- 1 November 2013
- Published by Springer Nature
- p. 53-74
Predictor Ranking using Modified Zhegalkin Functions
- 1 November 2013
- Published by Springer Nature
- p. 53-74
Predictor Ranking using Modified Zhegalkin Functions
- 1 November 2013
- Published by Springer Nature
- p. 39-51
Determining Gene Function in Boolean Networks using SAT
- 1 November 2013
- Published by Springer Nature
- p. 39-51
Determining Gene Function in Boolean Networks using SAT
- 1 November 2013
- Published by Springer Nature
- p. 25-38
Predictor Set Inference using SAT
- 1 November 2013
- Published by Springer Nature
- p. 1-21
Introduction
- Open Access
- 1 January 2012
- Published by Springer Nature in BMC Genomics
- Vol. 13 (Suppl 6) , S5
Application of Max-SAT-based ATPG to optimal cancer therapy design
Cancer and other gene related diseases are usually caused by a failure in the signaling pathway between genes and cells. These failures can occur in different areas of the gene regulatory network, but can be abstracted as faults in the regulatory function. For effective cancer treatment, it is imperative to identify faults and select appropriate drugs to treat the faults. In this paper, we present an extensible Max-SAT based automatic test pattern generation (ATPG) algorithm for cancer therapy. This ATPG algorithm is based on Boolean Satisfiability (SAT) and utilizes the stuck-at fault model for representing signaling faults. A weighted partial Max-SAT formulation is used to enable efficient selection of the most effective drug.
- 1 January 2012
- Published by Springer Nature in BMC Genomics
- Vol. 13 (Suppl 6) , S5
Open AccessApplication of Max-SAT-based ATPG to optimal cancer therapy design
Cancer and other gene related diseases are usually caused by a failure in the signaling pathway between genes and cells. These failures can occur in different areas of the gene regulatory network, but can be abstracted as faults in the regulatory function. For effective cancer treatment, it is imperative to identify faults and select appropriate drugs to treat the faults. In this paper, we present an extensible Max-SAT based automatic test pattern generation (ATPG) algorithm for cancer therapy. This ATPG algorithm is based on Boolean Satisfiability (SAT) and utilizes the stuck-at fault model for representing signaling faults. A weighted partial Max-SAT formulation is used to enable efficient selection of the most effective drug.